Wardwizard Healthcare Ltd Appoints New Statutory Auditors and Updates Official Website
Wardwizard Healthcare Ltd, formerly known as Ayoki Mercantile Limited, has announced significant corporate updates following a Board of Directors meeting held on July 16, 2026. The company confirmed the appointment of a new statutory auditor to fill a casual vacancy and initiated a transition to a new official website to align with branding requirements.The Board approved the appointment of M/s M G S A & Company (FRN: 022481C) as the Statutory Auditor for the company. This appointment follows the resignation of M/s. Mahesh Udhwani & Associates. The appointed firm will serve an initial term of five consecutive years, subject to approval by members at the Annual General Meeting scheduled for FY 2026-27. This term will continue until the conclusion of the AGM held in FY 2030-31.
In a related update, the company officially changed its website domain to https://wardwizardhealthcare.com/, effective July 16, 2026. The change is intended to support current branding and business requirements. To ensure continuity for investors and stakeholders, the previous website at https://www.ayokimerchantile.com/ will remain active and will automatically redirect all users to the new platform. The updated site will host all corporate information, financial results, and governance disclosures.
The professional profile of the appointed auditing firm is detailed below:
| Detail | Information |
|---|---|
| Firm Name | M/S. MGSA & COMPANY |
| FRN No. | 022481C |
| Date of Establishment | 29/11/2016 |
| Organization Setup | A team of 10 professionals including qualified professionals and audit staff members |
| Nature of Services | Direct and Indirect Taxation Consultancy, GST Registration, Statutory Audits, and Financial Advisory |
Stock Price Movement
Wardwizard Healthcare Ltd shares settled up 4.98% to ₹45.34 at the close of trade on Monday. The stock remained locked and traded completely flat throughout its intraday range of ₹45.34 to ₹45.34.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.